Total Payments
$94,979
2024 Payments
$35,578
Companies
9
Transactions
50
Payment Breakdown by Category
Consulting$53,554 (56.4%)
Travel$19,936 (21.0%)
Other$14,377 (15.1%)
Research$5,383 (5.7%)
Food & Beverage$1,730 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $53,554 | 14 | 56.4% |
| Travel and Lodging | $19,936 | 19 | 21.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,377 | 5 | 15.1% |
| Unspecified | $5,383 | 1 | 5.7% |
| Food and Beverage | $1,730 | 11 | 1.8% |
Payments by Type
General
$89,596
49 transactions
Research
$5,383
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $60,892 | 23 | $0 (2024) |
| Novo Nordisk AS | $17,853 | 13 | $0 (2018) |
| Eli Lilly and Company | $6,490 | 7 | $0 (2022) |
| PFIZER INC. | $3,980 | 2 | $0 (2019) |
| Genentech, Inc. | $2,250 | 1 | $0 (2023) |
| SANOFI US SERVICES INC. | $1,935 | 1 | $0 (2024) |
| Celgene Corporation | $900.00 | 1 | $0 (2019) |
| VERTEX PHARMACEUTICALS INCORPORATED | $550.00 | 1 | $0 (2019) |
| Medtronic MiniMed, Inc. | $128.71 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,578 | 11 | SANOFI-AVENTIS U.S. LLC ($33,643) |
| 2023 | $29,500 | 14 | SANOFI-AVENTIS U.S. LLC ($27,250) |
| 2022 | $132.88 | 3 | Eli Lilly and Company ($132.88) |
| 2019 | $5,430 | 4 | PFIZER INC. ($3,980) |
| 2018 | $8,851 | 6 | Novo Nordisk AS ($8,851) |
| 2017 | $15,487 | 12 | Novo Nordisk AS ($9,002) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | In-kind items and services | $14,202.60 | General |
| 10/16/2024 | SANOFI-AVENTIS U.S. LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,647.00 | General |
| 10/16/2024 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | In-kind items and services | $549.23 | General |
| 10/16/2024 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | In-kind items and services | $213.59 | General |
| 08/19/2024 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $1,935.00 | General |
| 06/30/2024 | SANOFI-AVENTIS U.S. LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $500.00 | General |
| 06/30/2024 | SANOFI-AVENTIS U.S. LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $250.00 | General |
| 06/21/2024 | SANOFI-AVENTIS U.S. LLC | — | Consulting Fee | Cash or cash equivalent | $2,903.00 | General |
| 06/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Consulting Fee | Cash or cash equivalent | $4,837.50 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $338.33 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | In-kind items and services | $201.40 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Consulting Fee | Cash or cash equivalent | $8,865.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | In-kind items and services | $673.91 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | In-kind items and services | $376.45 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | In-kind items and services | $237.03 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $170.01 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | Cash or cash equivalent | $108.68 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | Cash or cash equivalent | $102.96 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/20/2023 | SANOFI-AVENTIS U.S. LLC | — | Consulting Fee | Cash or cash equivalent | $7,979.00 | General |
| 06/22/2023 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Consulting Fee | Cash or cash equivalent | $7,799.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/22/2023 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $368.57 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/22/2023 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Travel and Lodging | Cash or cash equivalent | $348.40 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/22/2023 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | Cash or cash equivalent | $156.22 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/22/2023 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Travel and Lodging | Cash or cash equivalent | $64.54 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/26/2023 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
About Dr. Stephen Gitelman, M.D
Dr. Stephen Gitelman, M.D is a Pediatrics healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063440980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Gitelman, M.D has received a total of $94,979 in payments from pharmaceutical and medical device companies, with $35,578 received in 2024. These payments were reported across 50 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($53,554).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Endocrinology
- Location San Francisco, CA
- Active Since 06/29/2006
- Last Updated 03/13/2012
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1063440980
Products in Payments
- Victoza (Drug) $17,853
- TZIELD (Biological) $15,911
- SOLIQUA 100/33 (Biological) $8,737
- Minimed 670G System (Device) $128.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in San Francisco
Dr. David Kessler, M.d, M.D
Pediatrics — Payments: $424,231
Pediatrics $424,231
Dr. Tonya Chaffee, Md, MD
Pediatrics — Payments: $400,708
Pediatrics $400,708
Dr. Jonathan Strober, M.d, M.D
Pediatrics — Payments: $236,818
Pediatrics $236,818
Jose Camacho, Md, MD
Pediatrics — Payments: $128,583
Pediatrics $128,583
Saleh Adi, M.d, M.D
Pediatrics — Payments: $103,628
Pediatrics $103,628
Dr. William Soulsby, Md, MD
Pediatrics — Payments: $80,000
Pediatrics $80,000